Abdominal Migraine in Children and Adults

Posted on July 15 2025, By: Cerebral Torque

Stay in the Loop on the Latest in Migraine:

Abdominal Migraine

A comprehensive guide to understanding abdominal migraine in children and adults
Updated July 2025

Overview and Definition

Abdominal migraine (AM) is a debilitating condition characterized by paroxysmal (sudden, recurring) episodes of abdominal pain accompanied by vasomotor symptoms (changes in blood vessel function causing pallor, flushing, or temperature changes), leading to a significant reduction in quality of life. While more commonly observed in children, AM is increasingly recognized in adults, though it remains rare and less well understood in this population.

Key Characteristics of Abdominal Migraine

  • Recurrent episodes: Intense, acute periumbilical (around the belly button) or midline abdominal pain
  • Associated symptoms: Anorexia (loss of appetite), nausea, vomiting, headache, photophobia (sensitivity to light), and pallor (pale appearance)
  • Episode duration: Typically 1-72 hours with symptom-free intervals
  • Family history: Strong association with migraine in family members
0.2-4.1%
Prevalence in Children
Reported prevalence range in pediatric populations worldwide
70%
Evolve to Migraine
Children with AM who develop migraine headaches in follow-up studies

Epidemiology

The prevalence and clinical outcomes of AM in adults are unclear due to limited and conflicting literature. Among children with recurrent abdominal pain, the estimated prevalence of AM ranges from 2.4% to 4.1%, with a mean age of onset of around seven years.

Population Demographics

  • Children: Female predominance with reported female-to-male ratio of 1.6:1
  • Adults: 18 cases reported in literature (11 females, 7 males); Age range: 20-59 years
  • Family history: Strong family history of migraine commonly noted in affected individuals

A longitudinal study from the UK that followed 54 children diagnosed with AM found that the condition resolved in approximately 61% of participants over an 8-10-year period. However, a significant proportion continued to experience recurrent abdominal pain during migraine attacks into adulthood.

Pathophysiology

Although the exact pathophysiology (how the disease works in the body) of AM is unclear, several contributing mechanisms have been proposed, including visceral hypersensitivity (increased sensitivity of internal organs), altered gut motility (abnormal movement of the digestive tract) - now referred to as "Disorders of Gut-Brain Interaction" - and psychological factors that influence the hypothalamic-pituitary-adrenal axis (the body's stress response system).

Understanding Medical Terms

  • Trigeminovascular System: A network of nerves and blood vessels in the head that, when activated, can cause pain and inflammation
  • CGRP: Calcitonin gene-related peptide - a neuroinflammatory protein that can cause blood vessel dilation and create pain signals
  • Enteric Nervous System: The "second brain" - a network of nerves in the digestive system that controls gut function

Proposed Mechanisms

  • Gut-Brain Axis: Bidirectional (two-way) communication system between the GI tract and CNS (central nervous system)
  • Serotonin (5-HT): Key neurotransmitter (chemical messenger) in regulation, with fluctuations affecting neuronal excitability (nerve activity)
  • Trigeminovascular System: Activation leads to neurogenic inflammation (nerve-caused swelling) and release of proinflammatory peptides (proteins that cause inflammation)
  • CGRP: Potent vasodilator (blood vessel widener) expressed in enteric nervous system (gut's nerve network), can induce severe GI symptoms
  • Psychological factors: Adverse life experiences and stress are recognized risk factors

Additionally, it is hypothesized that AM shares pathophysiological mechanisms with traditional migraine. Activation of the trigeminovascular system can lead to neurogenic inflammation and the release of proinflammatory peptides such as substance P, vasoactive intestinal peptide (VIP), and calcitonin gene-related peptide (CGRP).

Pediatric Presentation

Abdominal migraine is characterized by recurrent episodes of abdominal pain in an otherwise healthy child who is normal between attacks. The pain is typically midline or poorly localized, moderate to severe in intensity, and associated with at least two additional features such as anorexia, nausea, vomiting, or pallor.

Comparison of Overlapping Symptoms

Symptom Cyclic Vomiting Syndrome Abdominal Migraine Migraine Headache
Vomiting 100% 39-72% 40-69%
Abdominal Pain 3-81% 100% 10-55%
Headache 38-59% 31-50% 100%
Pallor 87% 90-100% 23-88%
Anorexia 74% 91-98% 13-93%
Nausea 72% 73-91% 46-100%
Mean Age 5 years 9 years 11 years

Headache is not a prominent feature during attacks and may be overlooked if the child is not asked about it. Photophobia or phonophobia are uncommon. Most children stop having attacks by early adolescence, but rarely attacks may persist into adulthood.

Adult Presentation

Adult patients with AM often experience symptoms similar to those observed in children, particularly episodes of chronic abdominal pain. A distinguishing characteristic of AM is its paroxysmal (sudden, episodic) nature, which sets it apart from many other gastrointestinal disorders that typically present with chronic, more frequent symptoms.

Clinical Features in Adults

  • Pain location: Periumbilical (around the belly button), epigastric (upper stomach area), or midline regions
  • Pain character: Dull, crampy sensations to moderate or severe, intense episodes
  • Duration: Episodes range from 2 to 72 hours
  • Associated symptoms: Pallor (pale appearance), nausea, vomiting, anorexia (loss of appetite), photophobia (light sensitivity)
1-16
Years to Diagnosis
Delayed diagnosis range in adult cases due to nonspecific symptoms
67%
Personal Migraine History
Adult AM patients with personal history of migraine (12/18 cases)
56%
Family Migraine History
Adult AM patients with family history of migraine (10/18 cases)
20-59
Age Range (Years)
Reported age range in adult abdominal migraine cases

AM also shares clinical features with several adult-onset conditions, including cyclic vomiting syndrome (CVS), irritable bowel syndrome (IBS), cannabinoid hyperemesis syndrome, narcotic bowel syndrome, functional dyspepsia (FD - chronic indigestion), and centrally mediated abdominal pain syndrome (CAPS - chronic widespread abdominal pain).

Diagnostic Criteria

Currently, there are no established guidelines for diagnosing or managing AM in adults. Diagnosis should be based on a thorough medical history, physical examination, and appropriate investigations. AM is a diagnosis of exclusion.

Comparison of Diagnostic Criteria

Feature Rome IV (Pediatric) ICHD-3
Pain Location Periumbilical Midline abdominal
Pain Intensity Intense, acute Moderate to severe
Duration ≥1 hour 2-72 hours
Associated Symptoms At least 2 of: anorexia, nausea, vomiting, headache, photophobia, pallor At least 2 of: anorexia, nausea, vomiting, pallor, photophobia
Frequency Requirement ≥2 times in preceding 6 months At least 5 attacks
Chronicity Requirement Must fulfill criteria for at least 6 months prior to diagnosis No specific chronicity requirement
Important Note

AM is included only in the pediatric Rome IV criteria for functional gastrointestinal disorders and is not recognized in the adult Rome IV criteria. The ICHD-3 abdominal migraine criteria were developed primarily for pediatric populations.

Differential Diagnosis

The many causes of acute abdominal pain need to be considered in the differential diagnosis. Testing is determined by the history and physical examination, but the search for a mechanical process such as obstruction, kidney disorder, infection, or metabolic condition may be necessary.

Key Differential Diagnoses

  • Cyclic Vomiting Syndrome: Often marked by more severe vomiting and dehydration
  • Irritable Bowel Syndrome: More continuous pain with altered bowel habits
  • Functional Dyspepsia: Persistent epigastric discomfort, usually milder and less episodic
  • Cannabinoid Hyperemesis Syndrome: Linked to chronic cannabis use
  • Centrally Mediated Abdominal Pain Syndrome: Continuous widespread pain without symptom-free intervals
  • Organic causes: Appendicitis, pancreatitis, gallstones, peptic ulcer disease

Patient history should exclude "alarm symptoms" such as unexplained weight loss, melena (black, tarry stools indicating bleeding), rectal bleeding, or altered bowel habits, which may indicate more serious underlying pathology requiring further invasive investigations.

Management and Treatment

The approach to treatment depends on the patient's age, symptom severity, and individual response to therapy. Patient education and reassurance are central to management and represent the first-line treatment.

80%
Response to Simple Measures
Patients responding to resting in dark, quiet room with analgesics during attacks
60%
Patient Relief
Patients feeling relieved after understanding the condition and its symptoms

Treatment Approaches

  • Non-pharmacological: Patient education, dietary modifications, stress management, CBT (cognitive behavioral therapy)
  • Acute treatment: Triptans (specialized migraine medications like sumatriptan, eletriptan, rizatriptan), antiemetics (anti-nausea medications), NSAIDs (non-steroidal anti-inflammatory drugs)
  • Prophylactic: Topiramate, valproate, beta-blockers (propranolol), calcium channel blockers, pizotifen

Diet modification appears to play a significant role in managing AM in children, with up to 93% reporting at least one food type that worsens their gastrointestinal symptoms. However, the effectiveness of these dietary interventions in adults with AM remains unclear.

Treatment Terms Explained

  • Prophylactic treatment: Preventive medications taken regularly to reduce the frequency and severity of attacks
  • Acute treatment: Medications used during an attack to stop or reduce symptoms
  • Triptans: A class of medications specifically designed to treat migraines by affecting serotonin receptors

Prognosis and Long-term Outcomes

Most children with abdominal migraine evolve to develop migraine headaches. In one study of 54 children with abdominal migraine who were followed for 7 to 10 years, current or previous migraine headache was identified in 70 percent.

Long-term Outcomes

  • Resolution rate: Approximately 61% of children over 8-10 year follow-up
  • Evolution to migraine: 70% develop migraine headaches in longitudinal studies
  • Adult persistence: Some continue to experience symptoms into adulthood
  • Quality of life: Significant improvement with proper diagnosis and management

The true prevalence of AM in adults remains uncertain due to frequent misdiagnosis and underdiagnosis. Many adult patients undergo extensive investigations and multiple consultations before receiving an accurate diagnosis.

Clinical Summary and Future Directions

Based on current evidence, clinicians should consider AM in adults presenting with recurrent, paroxysmal abdominal pain accompanied by two or more associated symptoms such as anorexia, headache, vomiting, photophobia, or pallor, especially when symptoms persist for years. There is a clear need for further research to better characterize the clinical presentation, refine diagnostic criteria, and evaluate treatment options specifically for adults, as most current evidence is extrapolated from pediatric studies.

References

  1. Niriella MA, Jayasena H, Nishad N, Wijesingha IP, Prabagar K. Abdominal Migraine in Adults: A Narrative Review. Cureus. 2025;17(6):e85958. DOI: 10.7759/cureus.85958
  2. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1.
  3. Rome Foundation. Abdominal migraine. Rome IV Criteria. 2021. Available at: https://theromefoundation.org/rome-iv/rome-iv-criteria/
  4. Woodruff AE, Cieri NE, Abeles J, Seyse SJ. Abdominal migraine in adults: a review of pharmacotherapeutic options. Ann Pharmacother. 2013;47:e27.
  5. Evans RW, Whyte C. Cyclic vomiting syndrome and abdominal migraine in adults and children. Headache. 2013;53:984-993.
  6. Kunishi Y, Iwata Y, Ota M, et al. Abdominal migraine in a middle-aged woman. Intern Med. 2016;55:2793-2798.
  7. d'Onofrio F, Cologno D, Buzzi MG, et al. Adult abdominal migraine: a new syndrome or sporadic feature of migraine headache? A case report. Eur J Neurol. 2006;13:85-88.
  8. Hamed SA. A migraine variant with abdominal colic and Alice in Wonderland syndrome: a case report and review. BMC Neurol. 2010;10:2.
  9. Roberts JE, deShazo RD. Abdominal migraine, another cause of abdominal pain in adults. Am J Med. 2012;125:1135-1139.
  10. Abu-Arafeh I, Russell G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Arch Dis Child. 1995;72:413-417.
  11. Dignan F, Abu-Arafeh I, Russell G. The prognosis of childhood abdominal migraine. Arch Dis Child. 2001;84:415-418.
  12. Azmy DJ, Qualia CM. Review of abdominal migraine in children. Gastroenterol Hepatol (N Y). 2020;16:632-639.
  13. McFerron BA, Waseem S. Chronic recurrent abdominal pain. Pediatr Rev. 2012;33:509-517.
  14. Reust CE, Williams A. Recurrent abdominal pain in children. Am Fam Physician. 2018;97:785-793.
  15. Korterink J, Devanarayana NM, Rajindrajith S, Vlieger A, Benninga MA. Childhood functional abdominal pain: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2015;12:159-171.
  16. Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141:1285-1293.
  17. Falkenberg K, Bjerg HR, Olesen J. Two-hour CGRP infusion causes gastrointestinal hyperactivity: possible relevance for CGRP antibody treatment. Headache. 2020;60:929-937.
  18. Rutten JM, Korterink JJ, Venmans LM, Benninga MA, Tabbers MM. Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics. 2015;135:522-535.
  19. Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child. 1995;72:48-50.
  20. Kakisaka Y, Wakusawa K, Haginoya K, et al. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine? J Child Neurol. 2009;25:234-237.
  21. Huang RC, Palmer LJ, Forbes DA. Prevalence and pattern of childhood abdominal pain in an Australian general practice. J Paediatr Child Health. 2000;36:349-353.
  22. Bille B. Migraine in childhood and its prognosis. Cephalalgia. 1981;1:71-75.
  23. LenglarT L, Caula C, Moulding T, et al. Brain to belly: abdominal variants of migraine and functional abdominal pain disorders associated with migraine. J Neurogastroenterol Motil. 2021;27:482-494.
  24. Feldman W, McGrath P, Hodgson C, Ritter H, Shipman RT. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial. Am J Dis Child. 1985;139:1216-1218.
  25. Barr RG, Levine MD, Watkins JB. Recurrent abdominal pain of childhood due to lactose intolerance - A prospective study. N Engl J Med. 1979;300:1449-1452.